| Michael Hrag Merjanian, MD | |
|
Ucla Emergency Medicine, 924 Westwood Boulevard, Suite 300, Los Angeles, CA 90095-0001 | |
| (310) 794-0585 | |
| Not Available |
| Full Name | Michael Hrag Merjanian |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | Ucla Emergency Medicine, Los Angeles, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306230776 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A144396 (California) | Primary |
| Entity Name | Emergency Medicine Specialists Of Orange County |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740214733 PECOS PAC ID: 0840185005 Enrollment ID: O20040217000695 |
News Archive
Microbiotica, a leading player in microbiome-based therapeutics spun out of the Wellcome Sanger Institute, today announced that it has entered into a multi-year strategic collaboration with Genentech, a member of the Roche Group, to discover, develop and commercialize biomarkers, targets and medicines for inflammatory bowel disease.
New York was the hardest-hit U.S. state during the peak of the outbreak in the country. Now, a team of researchers from the New York Blood Center and Serimmune, an immune intelligence company, aimed to determine the prevalence of seropositive people for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, among healthy blood donors.
Drugs produced using biotechnology are among the most expensive medicines available. Biosimilars that offer a real alternative are becoming increasingly available on the market.
Treating babies who have sickle cell disease (SCD) with oral liquid hydroxyurea appears to prevent the onset of long-term complications triggered by this disease, according to results of a preliminary study by investigators at St. Jude Children's Research Hospital.
Miguel ángel Martínez, professor at the Faculty of Mathematics of the University of Valencia (UV) is the coordinator of MEDEA3, a statistical study on the geographical distribution of mortality from 16 causes in 26 Spanish cities of 11 autonomous communities.
› Verified 8 days ago
| Entity Name | Tarzana Emergency Medical Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235176702 PECOS PAC ID: 7113823014 Enrollment ID: O20040708001387 |
News Archive
Microbiotica, a leading player in microbiome-based therapeutics spun out of the Wellcome Sanger Institute, today announced that it has entered into a multi-year strategic collaboration with Genentech, a member of the Roche Group, to discover, develop and commercialize biomarkers, targets and medicines for inflammatory bowel disease.
New York was the hardest-hit U.S. state during the peak of the outbreak in the country. Now, a team of researchers from the New York Blood Center and Serimmune, an immune intelligence company, aimed to determine the prevalence of seropositive people for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, among healthy blood donors.
Drugs produced using biotechnology are among the most expensive medicines available. Biosimilars that offer a real alternative are becoming increasingly available on the market.
Treating babies who have sickle cell disease (SCD) with oral liquid hydroxyurea appears to prevent the onset of long-term complications triggered by this disease, according to results of a preliminary study by investigators at St. Jude Children's Research Hospital.
Miguel ángel Martínez, professor at the Faculty of Mathematics of the University of Valencia (UV) is the coordinator of MEDEA3, a statistical study on the geographical distribution of mortality from 16 causes in 26 Spanish cities of 11 autonomous communities.
› Verified 8 days ago
| Entity Name | Valley Presbyterian Emergency Medical Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033133103 PECOS PAC ID: 1951308105 Enrollment ID: O20061031000344 |
News Archive
Microbiotica, a leading player in microbiome-based therapeutics spun out of the Wellcome Sanger Institute, today announced that it has entered into a multi-year strategic collaboration with Genentech, a member of the Roche Group, to discover, develop and commercialize biomarkers, targets and medicines for inflammatory bowel disease.
New York was the hardest-hit U.S. state during the peak of the outbreak in the country. Now, a team of researchers from the New York Blood Center and Serimmune, an immune intelligence company, aimed to determine the prevalence of seropositive people for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, among healthy blood donors.
Drugs produced using biotechnology are among the most expensive medicines available. Biosimilars that offer a real alternative are becoming increasingly available on the market.
Treating babies who have sickle cell disease (SCD) with oral liquid hydroxyurea appears to prevent the onset of long-term complications triggered by this disease, according to results of a preliminary study by investigators at St. Jude Children's Research Hospital.
Miguel ángel Martínez, professor at the Faculty of Mathematics of the University of Valencia (UV) is the coordinator of MEDEA3, a statistical study on the geographical distribution of mortality from 16 causes in 26 Spanish cities of 11 autonomous communities.
› Verified 8 days ago
| Entity Name | Orange County Emergency Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508114711 PECOS PAC ID: 8123279056 Enrollment ID: O20121127000164 |
News Archive
Microbiotica, a leading player in microbiome-based therapeutics spun out of the Wellcome Sanger Institute, today announced that it has entered into a multi-year strategic collaboration with Genentech, a member of the Roche Group, to discover, develop and commercialize biomarkers, targets and medicines for inflammatory bowel disease.
New York was the hardest-hit U.S. state during the peak of the outbreak in the country. Now, a team of researchers from the New York Blood Center and Serimmune, an immune intelligence company, aimed to determine the prevalence of seropositive people for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, among healthy blood donors.
Drugs produced using biotechnology are among the most expensive medicines available. Biosimilars that offer a real alternative are becoming increasingly available on the market.
Treating babies who have sickle cell disease (SCD) with oral liquid hydroxyurea appears to prevent the onset of long-term complications triggered by this disease, according to results of a preliminary study by investigators at St. Jude Children's Research Hospital.
Miguel ángel Martínez, professor at the Faculty of Mathematics of the University of Valencia (UV) is the coordinator of MEDEA3, a statistical study on the geographical distribution of mortality from 16 causes in 26 Spanish cities of 11 autonomous communities.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Hrag Merjanian, MD Ucla Emergency Medicine, 924 Westwood Boulevard, Suite 300, Los Angeles, CA 90095-0001 Ph: (310) 794-0585 | Michael Hrag Merjanian, MD Ucla Emergency Medicine, 924 Westwood Boulevard, Suite 300, Los Angeles, CA 90095-0001 Ph: (310) 794-0585 |
News Archive
Microbiotica, a leading player in microbiome-based therapeutics spun out of the Wellcome Sanger Institute, today announced that it has entered into a multi-year strategic collaboration with Genentech, a member of the Roche Group, to discover, develop and commercialize biomarkers, targets and medicines for inflammatory bowel disease.
New York was the hardest-hit U.S. state during the peak of the outbreak in the country. Now, a team of researchers from the New York Blood Center and Serimmune, an immune intelligence company, aimed to determine the prevalence of seropositive people for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, among healthy blood donors.
Drugs produced using biotechnology are among the most expensive medicines available. Biosimilars that offer a real alternative are becoming increasingly available on the market.
Treating babies who have sickle cell disease (SCD) with oral liquid hydroxyurea appears to prevent the onset of long-term complications triggered by this disease, according to results of a preliminary study by investigators at St. Jude Children's Research Hospital.
Miguel ángel Martínez, professor at the Faculty of Mathematics of the University of Valencia (UV) is the coordinator of MEDEA3, a statistical study on the geographical distribution of mortality from 16 causes in 26 Spanish cities of 11 autonomous communities.
› Verified 8 days ago
Dr. Tiffany Hackett, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 8700 Beverly Blvd., Los Angeles, CA 90048 Phone: 310-967-1884 Fax: 310-967-1744 | |
Brennen J. Beatty, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 6041 Cadillac Ave, Los Angeles, CA 90034 Phone: 323-857-2000 | |
Matthew S. Berry, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 6041 Cadillac Ave, Los Angeles, CA 90034 Phone: 323-857-2000 | |
Phillip Gruber, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1200 N State St, Los Angeles, CA 90033 Phone: 323-226-6667 | |
Daniel Weingrow, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 757 Westwood Plz, Los Angeles, CA 90095 Phone: 310-825-2111 | |
Brian Truong, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 924 Westwood Blvd, Suite 300, Los Angeles, CA 90095 Phone: 310-794-0585 | |
Emily Michele Johnson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 San Pablo St, Los Angeles, CA 90033 Phone: 323-442-9922 |